2-151666042-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001164507.2(NEB):​c.5031+48A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.141 in 1,544,304 control chromosomes in the GnomAD database, including 22,433 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.19 ( 3947 hom., cov: 32)
Exomes 𝑓: 0.14 ( 18486 hom. )

Consequence

NEB
NM_001164507.2 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.310

Publications

3 publications found
Variant links:
Genes affected
NEB (HGNC:7720): (nebulin) This gene encodes nebulin, a giant protein component of the cytoskeletal matrix that coexists with the thick and thin filaments within the sarcomeres of skeletal muscle. In most vertebrates, nebulin accounts for 3 to 4% of the total myofibrillar protein. The encoded protein contains approximately 30-amino acid long modules that can be classified into 7 types and other repeated modules. Protein isoform sizes vary from 600 to 800 kD due to alternative splicing that is tissue-, species-,and developmental stage-specific. Of the 183 exons in the nebulin gene, at least 43 are alternatively spliced, although exons 143 and 144 are not found in the same transcript. Of the several thousand transcript variants predicted for nebulin, the RefSeq Project has decided to create three representative RefSeq records. Mutations in this gene are associated with recessive nemaline myopathy. [provided by RefSeq, Sep 2009]
NEB Gene-Disease associations (from GenCC):
  • nemaline myopathy 2
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P, Ambry Genetics
  • childhood-onset nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • intermediate nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • typical nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • lethal multiple pterygium syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • severe congenital nemaline myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 2-151666042-T-C is Benign according to our data. Variant chr2-151666042-T-C is described in ClinVar as Benign. ClinVar VariationId is 257816.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.477 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NEBNM_001164507.2 linkc.5031+48A>G intron_variant Intron 41 of 181 ENST00000427231.7 NP_001157979.2
NEBNM_001164508.2 linkc.5031+48A>G intron_variant Intron 41 of 181 ENST00000397345.8 NP_001157980.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NEBENST00000397345.8 linkc.5031+48A>G intron_variant Intron 41 of 181 5 NM_001164508.2 ENSP00000380505.3
NEBENST00000427231.7 linkc.5031+48A>G intron_variant Intron 41 of 181 5 NM_001164507.2 ENSP00000416578.2
NEBENST00000409198.5 linkc.5031+48A>G intron_variant Intron 41 of 149 5 ENSP00000386259.1

Frequencies

GnomAD3 genomes
AF:
0.193
AC:
29308
AN:
151988
Hom.:
3925
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.341
Gnomad AMI
AF:
0.148
Gnomad AMR
AF:
0.120
Gnomad ASJ
AF:
0.154
Gnomad EAS
AF:
0.493
Gnomad SAS
AF:
0.283
Gnomad FIN
AF:
0.118
Gnomad MID
AF:
0.120
Gnomad NFE
AF:
0.105
Gnomad OTH
AF:
0.178
GnomAD2 exomes
AF:
0.177
AC:
37585
AN:
212230
AF XY:
0.177
show subpopulations
Gnomad AFR exome
AF:
0.350
Gnomad AMR exome
AF:
0.100
Gnomad ASJ exome
AF:
0.160
Gnomad EAS exome
AF:
0.481
Gnomad FIN exome
AF:
0.125
Gnomad NFE exome
AF:
0.105
Gnomad OTH exome
AF:
0.157
GnomAD4 exome
AF:
0.136
AC:
188644
AN:
1392198
Hom.:
18486
Cov.:
29
AF XY:
0.139
AC XY:
95102
AN XY:
686184
show subpopulations
African (AFR)
AF:
0.357
AC:
11371
AN:
31894
American (AMR)
AF:
0.104
AC:
4258
AN:
40982
Ashkenazi Jewish (ASJ)
AF:
0.156
AC:
3517
AN:
22556
East Asian (EAS)
AF:
0.514
AC:
20077
AN:
39052
South Asian (SAS)
AF:
0.281
AC:
21404
AN:
76088
European-Finnish (FIN)
AF:
0.125
AC:
6375
AN:
50820
Middle Eastern (MID)
AF:
0.139
AC:
582
AN:
4174
European-Non Finnish (NFE)
AF:
0.104
AC:
111718
AN:
1069260
Other (OTH)
AF:
0.163
AC:
9342
AN:
57372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
7960
15921
23881
31842
39802
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4634
9268
13902
18536
23170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.193
AC:
29378
AN:
152106
Hom.:
3947
Cov.:
32
AF XY:
0.195
AC XY:
14482
AN XY:
74362
show subpopulations
African (AFR)
AF:
0.341
AC:
14130
AN:
41448
American (AMR)
AF:
0.120
AC:
1837
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.154
AC:
536
AN:
3472
East Asian (EAS)
AF:
0.493
AC:
2553
AN:
5176
South Asian (SAS)
AF:
0.283
AC:
1360
AN:
4808
European-Finnish (FIN)
AF:
0.118
AC:
1255
AN:
10602
Middle Eastern (MID)
AF:
0.119
AC:
35
AN:
294
European-Non Finnish (NFE)
AF:
0.105
AC:
7143
AN:
67996
Other (OTH)
AF:
0.187
AC:
394
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1086
2172
3257
4343
5429
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
310
620
930
1240
1550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.147
Hom.:
446
Bravo
AF:
0.199
Asia WGS
AF:
0.414
AC:
1434
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nemaline myopathy 2 Benign:1
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Arthrogryposis multiplex congenita 6 Benign:1
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
9.5
DANN
Benign
0.71
PhyloP100
-0.31
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4664496; hg19: chr2-152522556; COSMIC: COSV50874219; COSMIC: COSV50874219; API